Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

aCollaborating Centre for Oxford University and The Chinese University of Hong Kong for Disaster and Medical Humanitarian Response, The Chinese University of Hong Kong, Hong Kong Special ...

This therapy may be delivered through the use of an adeno-associated virus (AAV) vector. However, as trials with follow-up for AAV-mediated therapy have only just begun, Giulio Cossu, MD ...

Darcis examined the potential impact of climate change on vector-borne diseases, including malaria, dengue, Zika, and chikungunya. He emphasized the complexity of predicting these effects ...

The therapy is a nonmultiplying gene therapy vector, or transporter, which is a modified form of the herpes virus. This vector carries the gene encoding the active part of botulinum toxin ...